Rocket Lab Investor Relations Contact Rocket Lab Media Contact About Rocket Lab Forward Looking Statements Use of Non-GAAP Financial Measures Adjusted EBITDA Other Non-GAAP Financial Measures ROCKET LAB CORPORATION AND SUBSIDIARIES The tables provided below reconcile the non-GAAP financial measures Adjusted EBITDA, Non-GAAP gross profit, Non-GAAP research and development, net, Non-GAAP selling, general and administrative, Non-GAAP operating expenses, Non-GAAP operating loss and Non-GAAP total other income (expense), net with the most directly comparable GAAP financial measures. See above for additional information on the use of these non-GAAP financial measures.<\/p>\n \u00a0Three Months Ended March 31, \u00a02026\u00a0\u00a0\u00a02025\u00a0NET LOSS$(45,022)\u00a0$(60,616)Depreciation\u00a07,514\u00a0\u00a0\u00a05,689\u00a0Amortization\u00a07,476\u00a0\u00a0\u00a03,018\u00a0Stock-based compensation expense\u00a028,116\u00a0\u00a0\u00a019,234\u00a0Transaction costs\u00a01,668\u00a0\u00a0\u00a01,378\u00a0Interest expense\u00a01,274\u00a0\u00a0\u00a06,795\u00a0Interest income\u00a0(10,149)\u00a0\u00a0(4,209)Change in fair value of contingent consideration\u00a0187\u00a0\u00a0\u00a0\u2014\u00a0Benefit for income taxes\u00a0(1,792)\u00a0\u00a0(813)(Gain) loss on foreign exchange\u00a0(156)\u00a0\u00a0134\u00a0Accretion of marketable securities and cash equivalents purchased at a discount\u00a0(458)\u00a0\u00a0(585)(Gain) loss on disposal of assets\u00a0(409)\u00a0\u00a013\u00a0ADJUSTED EBITDA$(11,751)\u00a0$(29,962) \u00a0Three Months Ended March 31, \u00a02026\u00a0\u00a0\u00a02025\u00a0GAAP Gross profit$76,493\u00a0\u00a0$35,247\u00a0Stock-based compensation\u00a03,506\u00a0\u00a0\u00a03,920\u00a0Amortization of purchased intangibles and favorable lease\u00a06,094\u00a0\u00a0\u00a01,823\u00a0Non-GAAP Gross profit$86,093\u00a0\u00a0$40,990\u00a0Non-GAAP Gross margin\u00a043.0\u00a0%\u00a0\u00a033.4\u00a0%\u00a0\u00a0\u00a0\u00a0GAAP Research and development, net$80,513\u00a0\u00a0$55,109\u00a0Stock-based compensation\u00a0(5,846)\u00a0\u00a0(4,894)Amortization of purchased intangibles and favorable lease\u00a0\u2014\u00a0\u00a0\u00a0(165)Non-GAAP Research and development, net$74,667\u00a0\u00a0$50,050\u00a0\u00a0\u00a0\u00a0\u00a0GAAP Selling, general and administrative$51,949\u00a0\u00a0$39,326\u00a0Stock-based compensation\u00a0(18,764)\u00a0\u00a0(10,420)Amortization of purchased intangibles and favorable lease\u00a0(1,105)\u00a0\u00a0(776)Transaction costs\u00a0(1,668)\u00a0\u00a0(1,378)Non-GAAP Selling, general and administrative$30,412\u00a0\u00a0$26,752\u00a0\u00a0\u00a0\u00a0\u00a0GAAP Operating expenses$132,462\u00a0\u00a0$94,435\u00a0Stock-based compensation\u00a0(24,610)\u00a0\u00a0(15,314)Amortization of purchased intangibles and favorable lease\u00a0(1,105)\u00a0\u00a0(941)Transaction costs\u00a0(1,668)\u00a0\u00a0(1,378)Non-GAAP Operating expenses$105,079\u00a0\u00a0$76,802\u00a0\u00a0\u00a0\u00a0\u00a0GAAP Operating loss$(55,969)\u00a0$(59,188)Total non-GAAP adjustments\u00a036,983\u00a0\u00a0\u00a023,376\u00a0Non-GAAP Operating loss$(18,986)\u00a0$(35,812)\u00a0\u00a0\u00a0\u00a0GAAP Total other income (expense), net$9,155\u00a0\u00a0$(2,241)(Gain) loss on foreign exchange\u00a0(156)\u00a0\u00a0134\u00a0(Gain) loss on disposal of assets\u00a0(409)\u00a0\u00a013\u00a0Change in fair value of contingent consideration\u00a0187\u00a0\u00a0\u00a0\u2014\u00a0Non-GAAP Total other income (expense), net$8,777\u00a0\u00a0$(2,094)
Patrick Vorenkamp
investors@rocketlabusa.com<\/a><\/p>\n
Murielle Baker
media@rocketlabusa.com<\/a><\/p>\n
Rocket Lab is a leading space company that provides launch services, spacecraft, payloads and satellite components serving commercial, government, and national security markets. Rocket Lab\u2019s Electron rocket is the world\u2019s most frequently launched orbital small rocket; its HASTE rocket provides hypersonic test launch capability for the U.S. government and allied nations; and its Neutron launch vehicle in development will unlock medium launch for constellation deployment, national security and exploration missions. Rocket Lab\u2019s spacecraft and satellite components have enabled more than 1,700 missions spanning commercial, defense and national security missions including GPS, constellations, and exploration missions to the Moon, Mars, and Venus. Rocket Lab is a publicly listed company on the Nasdaq stock exchange (RKLB). Learn more at www.rocketlabcorp.com<\/a>.<\/p>\n
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d) and Section 21E of the Securities Exchange Act of 1934, as amended (the \u201cExchange Act\u201d). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our expectations of financial results for the second quarter of 2026, launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development and anticipated timeline to launch, operational expansion and business strategy are forward-looking statements. The words \u201cbelieve,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cestimate,\u201d \u201cpotential,\u201d \u201ccontinue,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cexpect,\u201d \u201cstrategy,\u201d \u201cfuture,\u201d \u201ccould,\u201d \u201cwould,\u201d \u201cproject,\u201d \u201cplan,\u201d \u201ctarget,\u201d and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the \u201cSEC\u201d), accessible on the SEC\u2019s website at www.sec.gov<\/a> and the Investor Relations section of our website at www.investors.rocketlabcorp.com<\/a>, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management\u2019s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.<\/p>\n
We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America (\u201cGAAP\u201d) with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company’s ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly filed reports in their entirety and not to rely on any single financial measure. Reconciliation of the non-GAAP financial information to the corresponding GAAP measures for the historical periods disclosed are included at the end of the tables in this press release. We have not provided a reconciliation for forward-looking non-GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. The following definitions are provided:<\/p>\n
EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from net income or loss to determine Adjusted EBITDA. Management believes this measure provides investors meaningful insight into results from ongoing operations.<\/p>\n
Non-GAAP gross profit, gross margin, research and development, net, selling, general and administrative, operating expenses, operating loss and total other income (expense), net, further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from the applicable GAAP financial measure. Management believes these non-GAAP measures provide investors meaningful insight into results from ongoing operations.<\/p>\n
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025
(unaudited; in thousands, except share and per share data)\u00a0Three Months Ended March 31,\u00a0\u00a02026\u00a0\u00a0\u00a02025\u00a0Revenues:\u00a0\u00a0\u00a0Product revenues$127,488\u00a0\u00a0$80,804\u00a0Service revenues\u00a072,860\u00a0\u00a0\u00a041,765\u00a0Total revenues\u00a0200,348\u00a0\u00a0\u00a0122,569\u00a0Cost of revenues:\u00a0\u00a0\u00a0Cost of product revenues\u00a081,084\u00a0\u00a0\u00a053,869\u00a0Cost of service revenues\u00a042,771\u00a0\u00a0\u00a033,453\u00a0Total cost of revenues\u00a0123,855\u00a0\u00a0\u00a087,322\u00a0Gross profit\u00a076,493\u00a0\u00a0\u00a035,247\u00a0Operating expenses:\u00a0\u00a0\u00a0Research and development, net\u00a080,513\u00a0\u00a0\u00a055,109\u00a0Selling, general and administrative\u00a051,949\u00a0\u00a0\u00a039,326\u00a0Total operating expenses\u00a0132,462\u00a0\u00a0\u00a094,435\u00a0Operating loss\u00a0(55,969)\u00a0\u00a0(59,188)Other income (expense):\u00a0\u00a0\u00a0Interest expense\u00a0(1,274)\u00a0\u00a0(6,795)Interest income\u00a010,149\u00a0\u00a0\u00a04,209\u00a0Gain (loss) on foreign exchange\u00a0156\u00a0\u00a0\u00a0(134)Other income, net\u00a0124\u00a0\u00a0\u00a0479\u00a0Total other income (expense), net\u00a09,155\u00a0\u00a0\u00a0(2,241)Loss before income taxes\u00a0(46,814)\u00a0\u00a0(61,429)Benefit for income taxes\u00a01,792\u00a0\u00a0\u00a0813\u00a0Net loss$(45,022)\u00a0$(60,616)Net loss per share attributable to Rocket Lab Corporation:\u00a0\u00a0\u00a0Basic and diluted$(0.07)\u00a0$(0.12)Weighted-average common shares outstanding:\u00a0\u00a0\u00a0Basic and diluted\u00a0605,434,642\u00a0\u00a0\u00a0505,614,185\u00a0 ROCKET LAB CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
AS OF MARCH 31, 2026 AND DECEMBER 31, 2025
(unaudited; in thousands, except share and per share values)
\u00a0March 31, 2026
(unaudited) \u00a0December 31, 2025Assets\u00a0\u00a0\u00a0Current assets:\u00a0\u00a0\u00a0Cash and cash equivalents$1,205,499\u00a0\u00a0$828,660\u00a0Marketable securities, current\u00a0177,852\u00a0\u00a0\u00a0187,917\u00a0Accounts receivable, net\u00a074,955\u00a0\u00a0\u00a039,001\u00a0Contract assets\u00a075,036\u00a0\u00a0\u00a061,606\u00a0Inventories\u00a0183,146\u00a0\u00a0\u00a0158,407\u00a0Prepaids and other current assets\u00a083,874\u00a0\u00a0\u00a089,953\u00a0Total current assets\u00a01,800,362\u00a0\u00a0\u00a01,365,544\u00a0Non-current assets:\u00a0\u00a0\u00a0Property, plant and equipment, net\u00a0343,988\u00a0\u00a0\u00a0319,473\u00a0Intangible assets, net\u00a0220,567\u00a0\u00a0\u00a0224,746\u00a0Goodwill\u00a0208,738\u00a0\u00a0\u00a0205,750\u00a0Right-of-use assets – operating leases\u00a090,933\u00a0\u00a0\u00a090,371\u00a0Right-of-use assets – finance leases\u00a013,767\u00a0\u00a0\u00a013,895\u00a0Marketable securities, non-current\u00a093,494\u00a0\u00a0\u00a082,247\u00a0Restricted cash\u00a05,524\u00a0\u00a0\u00a04,885\u00a0Deferred income tax assets, net\u00a0849\u00a0\u00a0\u00a01,895\u00a0Other non-current assets\u00a041,719\u00a0\u00a0\u00a015,672\u00a0Total assets$2,819,941\u00a0\u00a0$2,324,478\u00a0Liabilities and Stockholders\u2019 Equity\u00a0\u00a0\u00a0Current liabilities:\u00a0\u00a0\u00a0Trade payables$63,112\u00a0\u00a0$72,699\u00a0Accrued expenses\u00a033,546\u00a0\u00a0\u00a019,299\u00a0Employee benefits payable\u00a040,720\u00a0\u00a0\u00a025,803\u00a0Contract liabilities\u00a0241,412\u00a0\u00a0\u00a0195,438\u00a0Other current liabilities\u00a023,555\u00a0\u00a0\u00a021,237\u00a0Total current liabilities\u00a0402,345\u00a0\u00a0\u00a0334,476\u00a0Non-current liabilities:\u00a0\u00a0\u00a0Convertible senior notes, net\u00a036,869\u00a0\u00a0\u00a0152,395\u00a0Long-term borrowings, net\u00a01,716\u00a0\u00a0\u00a01,716\u00a0Non-current operating lease liabilities\u00a085,517\u00a0\u00a0\u00a085,191\u00a0Non-current finance lease liabilities\u00a014,568\u00a0\u00a0\u00a014,653\u00a0Deferred income tax liabilities\u00a01,352\u00a0\u00a0\u00a01,241\u00a0Other non-current liabilities\u00a013,207\u00a0\u00a0\u00a012,952\u00a0Total liabilities\u00a0555,574\u00a0\u00a0\u00a0602,624\u00a0COMMITMENTS AND CONTINGENCIES\u00a0\u00a0\u00a0Stockholders\u2019 equity:\u00a0\u00a0\u00a0Preferred stock, $0.0001 par value; authorized shares: 100,000,000; issued and outstanding shares: 45,951,250 at March\u00a031, 2026 and December\u00a031, 2025\u00a05\u00a0\u00a0\u00a05\u00a0Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued shares: 621,718,750 and 589,525,802 at March\u00a031, 2026 and December\u00a031, 2025, respectively; outstanding shares: 575,767,500 and 543,574,552 at March\u00a031, 2026 and December\u00a031, 2025, respectively\u00a058\u00a0\u00a0\u00a054\u00a0Treasury stock, at cost; shares: 45,951,250 at March\u00a031, 2026 and December\u00a031, 2025\u00a0\u2014\u00a0\u00a0\u00a0\u2014\u00a0Additional paid-in capital\u00a03,324,206\u00a0\u00a0\u00a02,735,669\u00a0Accumulated deficit\u00a0(1,056,932)\u00a0\u00a0(1,011,910)Accumulated other comprehensive loss\u00a0(2,970)\u00a0\u00a0(1,964)Total stockholders\u2019 equity\u00a02,264,367\u00a0\u00a0\u00a01,721,854\u00a0Total liabilities and stockholders\u2019 equity$2,819,941\u00a0\u00a0$2,324,478\u00a0 ROCKET LAB CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025
(unaudited; in thousands)\u00a0For the Three Months Ended March 31,\u00a0\u00a02026\u00a0\u00a0\u00a02025\u00a0CASH FLOWS FROM OPERATING ACTIVITIES:\u00a0\u00a0\u00a0Net loss$(45,022)\u00a0$(60,616)Adjustments to reconcile net loss to net cash used in operating activities:\u00a0\u00a0\u00a0Depreciation and amortization\u00a014,990\u00a0\u00a0\u00a08,707\u00a0Stock-based compensation expense\u00a028,116\u00a0\u00a0\u00a019,234\u00a0(Gain) loss on disposal of assets\u00a0(409)\u00a0\u00a013\u00a0Amortization of debt issuance costs and discount\u00a0133\u00a0\u00a0\u00a0831\u00a0Noncash lease expense\u00a02,797\u00a0\u00a0\u00a01,519\u00a0Change in the fair value of contingent consideration\u00a0187\u00a0\u00a0\u00a0\u2014\u00a0Accretion of marketable securities purchased at a discount\u00a0(458)\u00a0\u00a0(561)Deferred income taxes\u00a01,155\u00a0\u00a0\u00a0(585)Changes in operating assets and liabilities:\u00a0\u00a0\u00a0Accounts receivable, net\u00a0(35,662)\u00a0\u00a0(2,974)Contract assets\u00a0(13,434)\u00a0\u00a02,165\u00a0Inventories\u00a0(24,571)\u00a0\u00a0(6,308)Prepaids and other current assets\u00a04,081\u00a0\u00a0\u00a0(9,617)Other non-current assets\u00a0(26,098)\u00a0\u00a01,571\u00a0Trade payables\u00a0(8,161)\u00a0\u00a09,779\u00a0Accrued expenses\u00a010,825\u00a0\u00a0\u00a0(2,712)Employee benefits payables\u00a01,309\u00a0\u00a0\u00a0(253)Contract liabilities\u00a045,753\u00a0\u00a0\u00a0(9,294)Other current liabilities\u00a0(2,941)\u00a0\u00a0(3,699)Non-current lease liabilities\u00a0(2,993)\u00a0\u00a0(1,670)Other non-current liabilities\u00a071\u00a0\u00a0\u00a0245\u00a0Net cash used in operating activities\u00a0(50,332)\u00a0\u00a0(54,225)CASH FLOWS FROM INVESTING ACTIVITIES:\u00a0\u00a0\u00a0Purchases of property, equipment and software\u00a0(27,065)\u00a0\u00a0(28,677)Proceeds on disposal of assets\u00a0715\u00a0\u00a0\u00a016\u00a0Cash paid for business combinations, net of acquired cash\u00a0(8,021)\u00a0\u00a0\u2014\u00a0Purchases of marketable securities\u00a0(91,328)\u00a0\u00a0(84,639)Maturities of marketable securities\u00a089,979\u00a0\u00a0\u00a084,699\u00a0Net cash used in investing activities\u00a0(35,720)\u00a0\u00a0(28,601)CASH FLOWS FROM FINANCING ACTIVITIES:\u00a0\u00a0\u00a0Proceeds from ATM Equity Offerings\u00a0450,347\u00a0\u00a0\u00a092,806\u00a0Issuance costs related to ATM Equity Offerings\u00a0(4,740)\u00a0\u00a0(2,088)Proceeds from the exercise of stock options\u00a01,081\u00a0\u00a0\u00a048\u00a0Proceeds from Employee Stock Purchase Plan\u00a04,189\u00a0\u00a0\u00a02,237\u00a0Proceeds from sale of employees restricted stock units to cover taxes\u00a052,337\u00a0\u00a0\u00a017,310\u00a0Minimum tax withholding paid on behalf of employees for restricted stock units\u00a0(39,848)\u00a0\u00a0(16,577)Proceeds from secured term loans\u00a0\u2014\u00a0\u00a0\u00a025,000\u00a0Repayments on secured term loan\u00a0\u2014\u00a0\u00a0\u00a0(2,894)Payment of debt issuance costs\u00a0\u2014\u00a0\u00a0\u00a0(278)Finance lease principal payments\u00a0(73)\u00a0\u00a0(61)Net cash provided by financing activities\u00a0463,293\u00a0\u00a0\u00a0115,503\u00a0Effect of exchange rate changes on cash and cash equivalents\u00a0237\u00a0\u00a0\u00a0272\u00a0Net increase in cash and cash equivalents and restricted cash\u00a0377,478\u00a0\u00a0\u00a032,949\u00a0Cash and cash equivalents, and restricted cash, beginning of period\u00a0833,545\u00a0\u00a0\u00a0275,302\u00a0Cash and cash equivalents, and restricted cash, end of period$1,211,023\u00a0\u00a0$308,251\u00a0 ROCKET LAB CORPORATION AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025
(unaudited; in thousands) <\/p>\n![\"\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/05\/Rocket-Lab-Corporation.png\")
<\/p>\n","protected":false},"excerpt":{"rendered":"LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB), a global leader in…\n","protected":false},"author":2,"featured_media":276265,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23],"tags":[160240,64,63,160238,16151,160239,317610,128,285],"class_list":["post-656887","post","type-post","status-publish","format-standard","has-post-thumbnail","category-space","tag-rklb","tag-au","tag-australia","tag-nasdaqrklb","tag-rocket-lab","tag-rocket-lab-corporation","tag-rocket-lab-earnings","tag-science","tag-space"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/656887","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=656887"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/656887\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/276265"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=656887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=656887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=656887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}